Anna Rachelle Mislang — Flinders University

Area of research

Geriatrics and Gerontology · Oncology

Research interest

Research focused on Adverse effect and Geriatric oncology, with related work in Tolerability, Intensive care medicine, Temozolomide. Notable publications include 'Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group', 'Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations', and 'Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors'.

Recent publications

Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors

Journal for ImmunoTherapy of Cancer 2024cited by 63position: middledoi

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

Neuro-Oncology Advances 2023cited by 18position: middledoi

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers

Cancer Immunology Immunotherapy 2022cited by 20position: middledoi

Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group

Journal of Geriatric Oncology 2020cited by 79position: middledoi

Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations

Cancer Treatment Reviews 2017cited by 66position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Craig Underhill · Australian Research Council2 papers (2022–2024)Zhongmin Maxwell Wang · China National Pharmaceutical Group Corporation (China)2 papers (2022–2024)Ravindran Kanesvaran · SingHealth2 papers (2017–2020)Jermaine Coward · Cancer Council Queensland2 papers (2022–2024)Baiyong Li · China National Pharmaceutical Group Corporation (China)2 papers (2022–2024)Anita O’Donovan · Trinity College1 papers (2020–2020)Tanya M. Wildes · Hematology Oncology Associates1 papers (2017–2017)Ginah Nightingale · Thomas Jefferson University1 papers (2017–2017)Holly M. Holmes · University of Houston1 papers (2017–2017)— · 1 papers (2022–2022)Hong Wang · Universitat Politècnica de Catalunya1 papers (2022–2022)Yulong Zheng · Xuzhou Medical College1 papers (2022–2022)— · 1 papers (2017–2017)Chiara Russo · Université Claude Bernard Lyon 11 papers (2020–2020)— · 1 papers (2020–2020)Regina Gironés Sarrió · Leitat Technological Center1 papers (2020–2020)— · 1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)Nong Xu · Hangzhou First People's Hospital1 papers (2022–2022)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Geriatrics and Gerontology · Oncology →